Metropolitan Life Insurance CO Cue Biopharma, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$3.11 - $4.91 $5,964 - $9,417	1,918 New	1,918 $7,000
Q1 2022 May 12, 2022	SELL	$4.41 - $12.28 $38,256 - $106,529	-8,675 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$10.86 - $17.85 $94,210 - $154,848	8,675 New	8,675 $98,000
Q4 2021 Mar 30, 2023	SELL	$10.86 - $17.85 $4,354 - $7,157	-401 Reduced 4.42%	8,675 $98,000
Q4 2021 Feb 15, 2022	SELL	$10.86 - $17.85 $4,354 - $7,157	-401 Reduced 4.42%	8,675 $98,000
Q3 2021 Jun 21, 2023	BUY	$10.06 - $15.3 $91,304 - $138,862	9,076 New	9,076 $132,000
Q3 2021 Mar 30, 2023	BUY	$10.06 - $15.3 $3,028 - $4,605	301 Added 3.43%	9,076 $132,000
Q3 2021 Nov 15, 2021	BUY	$10.06 - $15.3 $3,028 - $4,605	301 Added 3.43%	9,076 $132,000
Q2 2021 Jun 21, 2023	BUY	$10.9 - $14.53 $95,647 - $127,500	8,775 New	8,775 $102,000
Q2 2021 Mar 30, 2023	BUY	$10.9 - $14.53 $12,306 - $16,404	1,129 Added 14.77%	8,775 $102,000
Q2 2021 Aug 16, 2021	BUY	$10.9 - $14.53 $95,560 - $127,384	8,767 Added 109587.5%	8,775 $102,000
Q1 2021 Jun 26, 2023	BUY	$11.2 - $16.09 $85,635 - $123,024	7,646 New	7,646 $93.3 Million
Q1 2021 Mar 30, 2023	SELL	$11.2 - $16.09 $13,540 - $19,452	-1,209 Reduced 13.65%	7,646 $93,000
Q1 2021 May 14, 2021	SELL	$11.2 - $16.09 $99,086 - $142,348	-8,847 Reduced 99.91%	8 $93,000
Q4 2020 Jun 22, 2023	BUY	$11.12 - $16.4 $98,467 - $145,222	8,855 New	8,855 $110,000
Q3 2020 Jun 26, 2023	BUY	$15.05 - $23.54 $133,267 - $208,446	8,855 New	8,855 $133,000
Q2 2020 Jun 26, 2023	BUY	$12.7 - $30.73 $112,458 - $272,114	8,855 New	8,855 $217,000
Q2 2020 Mar 30, 2023	BUY	$12.7 - $30.73 $21,590 - $52,241	1,700 Added 23.76%	8,855 $217,000
Q2 2020 Aug 14, 2020	BUY	$12.7 - $30.73 $21,590 - $52,241	1,700 Added 23.76%	8,855 $217,000
Q1 2020 Jul 12, 2023	BUY	$9.85 - $22.27 $70,476 - $159,341	7,155 New	7,155 $101,000
Q4 2019 Jul 12, 2023	BUY	$7.06 - $17.47 $50,514 - $124,997	7,155 New	7,155 $113,000
Q4 2019 Mar 30, 2023	BUY	$7.06 - $17.47 $50,514 - $124,997	7,155 New	7,155 $113,000
Q4 2019 Feb 14, 2020	BUY	$7.06 - $17.47 $50,514 - $124,997	7,155 New	7,155 $114,000

Others Institutions Holding CUE

# of Institutions

Shares Held

14.1M

Call Options Held

14.4K

Put Options Held

2.6K

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account